
AcousticaBio enables biologic drugs to move from infusion to injection. We help biopharmaceutical companies formulate new and existing biologics into ultra-high-concentration, small-volume subcutaneous injections, overcoming the viscosity, stability, and manufacturability challenges that typically limit injectable delivery. Powered by our proprietary, Harvard-patented acoustophoretic technology, we transform therapies traditionally administered through lengthy IV infusions into patient-friendly injections, without solvents or complex post-processing. The result: biologics that are easier to…
Annual Revenue$1M to $5M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.